Clinical Analysis of Repeat Balloon Eustachian Tube Dilatation

Q4 Medicine
Gab-Kyun Lee, Hyeon-su Kim, Hwabin Kim, Jung-woo Lee, Se-joon Oh, Soo-keun Kong
{"title":"Clinical Analysis of Repeat Balloon Eustachian Tube Dilatation","authors":"Gab-Kyun Lee, Hyeon-su Kim, Hwabin Kim, Jung-woo Lee, Se-joon Oh, Soo-keun Kong","doi":"10.3342/kjorl-hns.2023.00626","DOIUrl":null,"url":null,"abstract":"Background and Objectives Obstructive Eustachian tube dysfunction (OETD) is a complex condition in which middle ear ventilation control is impaired. OETD is often not improved by medication nor by nasal washing or nasal spray. On the other hand, balloon Eustachian tube dilatation (BETD) is an effective surgery in OETD although repeating BETD is controversial as it involves additional procedure such as ventilation tube, middle ear steroid irrigation, and trans-tympanic Eustachian tube probing in some cases. This study aims to analyze the clinical differences between patients who received single BETD and repeat BETD, and to evaluate the efficacy of repeat BETD.Subjects and Method For the study, 110 single groups, and 16 repeat groups were selected from patients who underwent BETD from Nov 2019 to Aug 2022. Age, gender, underlying diseases, history of rhinitis and smoking, and Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) were analyzed for the selected groups.Results There were no significant differences in gender, underlying disease, or history of rhinitis between the two groups. However, age was significantly younger in the repeat group (45.91 vs. 33.38, p=0.006), while smoking (5.64 vs. 1.66, p=0.01) was significantly higher in the single group. The rate of improvement in the ETDQ-7 was 81.3% in the single group and 69.2% in both initial and repeated surgeries in the repeat group. The complete remission rate was 60% in the single group, and 38.5% in both initial and repeated surgeries of the repeat group.Conclusion For patients who are unsatisfied with the first surgery, it is meaningful enough to recommend repeat BETD, for which additional procedures are performed simultaneously.","PeriodicalId":17844,"journal":{"name":"Korean Journal of Otorhinolaryngology-head and Neck Surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Otorhinolaryngology-head and Neck Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3342/kjorl-hns.2023.00626","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Objectives Obstructive Eustachian tube dysfunction (OETD) is a complex condition in which middle ear ventilation control is impaired. OETD is often not improved by medication nor by nasal washing or nasal spray. On the other hand, balloon Eustachian tube dilatation (BETD) is an effective surgery in OETD although repeating BETD is controversial as it involves additional procedure such as ventilation tube, middle ear steroid irrigation, and trans-tympanic Eustachian tube probing in some cases. This study aims to analyze the clinical differences between patients who received single BETD and repeat BETD, and to evaluate the efficacy of repeat BETD.Subjects and Method For the study, 110 single groups, and 16 repeat groups were selected from patients who underwent BETD from Nov 2019 to Aug 2022. Age, gender, underlying diseases, history of rhinitis and smoking, and Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7) were analyzed for the selected groups.Results There were no significant differences in gender, underlying disease, or history of rhinitis between the two groups. However, age was significantly younger in the repeat group (45.91 vs. 33.38, p=0.006), while smoking (5.64 vs. 1.66, p=0.01) was significantly higher in the single group. The rate of improvement in the ETDQ-7 was 81.3% in the single group and 69.2% in both initial and repeated surgeries in the repeat group. The complete remission rate was 60% in the single group, and 38.5% in both initial and repeated surgeries of the repeat group.Conclusion For patients who are unsatisfied with the first surgery, it is meaningful enough to recommend repeat BETD, for which additional procedures are performed simultaneously.
重复球囊咽鼓管扩张术的临床分析
背景和目的阻塞性咽鼓管功能障碍(OETD)是一种中耳通气控制受损的复杂病症。药物、鼻腔清洗或鼻腔喷雾通常都无法改善咽鼓管功能障碍。另一方面,气囊咽鼓管扩张术(BETD)是治疗咽鼓管功能障碍的有效手术方法,但由于重复进行 BETD 需要进行通气管、中耳类固醇灌洗、经鼓室咽鼓管探查等额外手术,因此存在争议。本研究旨在分析接受单次BETD和重复BETD患者的临床差异,并评估重复BETD的疗效。 研究对象和方法 本研究从2019年11月至2022年8月接受BETD的患者中选取110例单次组和16例重复组。结果 两组患者在性别、基础疾病、鼻炎史、吸烟史以及咽鼓管功能障碍问卷-7(ETDQ-7)方面无显著差异。然而,重复治疗组的年龄明显更小(45.91 对 33.38,P=0.006),而单次治疗组的吸烟率明显更高(5.64 对 1.66,P=0.01)。单次手术组的 ETDQ-7 改善率为 81.3%,重复手术组的首次和重复手术改善率均为 69.2%。结论 对于对首次手术不满意的患者,建议重复 BETD 是有意义的,因为重复 BETD 会同时进行额外的手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信